Even on an annualised basis ($8 million) NET is well short of their target. But I still do not get it. How can they have sales when their product is still being tested. Every man and his dog knows that IT products that are being tested can not sell. Buyers want proved products with track record.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.63M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| NET (ASX) Chart |
Day chart unavailable